Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Salicylazosulfapyridine 11177-H

 

CASRN: 599-79-1

Formula: C18-H14-N4-O5-S

Synonyms/Common Names

  • 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azobenzoic acid (9CI)
  • SASP
  • Sulfasalazine

Chemical Properties

Toxicity Effects (HSDB)

Short-Term Toxicity

  • 14-Day (Gavage)  (C61552)  Completed 
    • Rats: F344/N; Mice: B6C3F1
  • 13 weeks (Gavage)  (C61552)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R: 0, 84, 169, OR 337 M: 0, 675, 1350, OR 2700 MG/KG.

Long-Term Carcinogenicity

  • 2 & 3 years (Gavage)  (C61552B)  Completed 
    • TR-457 (NIH Number: 97-3373)  (Peer Review Approval 06/20/1995A )
      Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CASRN 599-79-1) in F344 Rats and B6C3F1 Mice (Gavage Studies)
    • Rats: F344/N; Mice: B6C3F1
    • Carcinogenesis Results
      • Male Rats Some Evidence 
      • Female Rats Some Evidence 
      • Male Mice Clear Evidence 
      • Female Mice Clear Evidence 
    • Dose: R: 84, 168, OR 337.5 MG/KG; 70/GROUP M: 675, 1350, OR 2700 MG/KG; 60/GROUP.

Special Studies

  • Toxicokinetic Study (Gavage)  (S0312)  Completed 
    • Citation: Zheng W, Winter SM, Mayersohn M, Bishop JB, Sipes IG. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice. Drug Metab Dispos. 1993 Nov-Dec;21(6):1091-7.Pubmed Abstract
    • Male Rats: F344/N; Male and Female Rats: F344/N; Male and Female Mice: B6C3F1
    • Dose: MICE:675, 1350, 2700 MG/KG (BOTH SEXES).

Genetic Toxicology

  • Chromosome Aberrations  (459882)  Completed 
    • Citation: Bishop, J.B., Witt, K.L., Gulati, D.K., and MacGregor, J.T. Evaluation of the mutagenicity of the Anti-inflammatory drug salicylazosulfapyridine (SASP). Mutagenesis Vol. 5 (1990) 549-554
    • Mice
    •  Negative (Nonstandard Protocol) 
  • Chromosome Aberrations  (724355)  Completed 
    • Mice
    •  Negative (Nonstandard Protocol) 
  • Chromosome Aberrations  (A93691)  Completed 
    • Mice
    •  Negative (Nonstandard Protocol) 
  • In Vitro Cytogenetics (CA/SCE)  (291257)  Completed 
    • Citation: Bishop, J.B., Witt, K.L., Gulati, D.K., and MacGregor, J.T. Evaluation of the mutagenicity of the Anti-inflammatory drug salicylazosulfapyridine (SASP). Mutagenesis Vol. 5 (1990) 549-554
    • Sister Chromatid Exchange Negative 
    • Chromosome Aberrations Negative 
  • Micronucleus  (107236)  Completed 
    • Rats: Fischer 344
    • Male Equivocal 
  • Micronucleus  (459882)  Completed 
    • Citation: Bishop, J.B., Witt, K.L., Gulati, D.K., and MacGregor, J.T. Evaluation of the mutagenicity of the Anti-inflammatory drug salicylazosulfapyridine (SASP). Mutagenesis Vol. 5 (1990) 549-554
    • Mice: B6C3F1
    • Male Negative 
  • Micronucleus  (724355)  Completed 
    • Mice: B6C3F1
    • Male Not a Valid Test 
  • Micronucleus  (A66124)  Completed 
    • Citation: Bishop, J.B., Witt, K.L., Gulati, D.K., and MacGregor, J.T. Evaluation of the mutagenicity of the Anti-inflammatory drug salicylazosulfapyridine (SASP). Mutagenesis Vol. 5 (1990) 549-554
    • Citation: Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194
    • Mice: B6C3F1
    • Male Positive 
    • Female Positive 
  • Micronucleus  (A72306)  Completed 
    • Mice: B6C3F1
    • Male Positive 
  • Micronucleus  (A93691)  Completed 
    • Mice: B6C3F1
    • Male Positive (Nonstandard Protocol) 
    • Female Positive 
  • Salmonella  (031562)  Completed 
    • Citation: Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. Salmonella mutagenicity tests. IV. Results from the testing of 300 chemicals Environ. Molec. Mutagen. Vol. 11 (Suppl 12) (1988) 1-158
    •  Negative 
  • Sister Chromatid Exchanges  (724355)  Completed 
    • Mice
    • Sister Chromatid  Negative (Nonstandard Protocol) 

Organ Systems Toxicity

  • greater than 120 days Continuous Breeding (Legacy) (Gavage)  (RACB90002)  Completed 
    • Citation: Final Report on the Reproductive Toxicity of Salicylazosulfapyridine in CD Sprague-Dawley Rats ?
    • Rats: Sprague Dawley
    • Dose: 0, 100, 200, 400, 600, 800 MG/KG; 0, 100, 200, 400 MG/KG/DAY; 0, 100, 200, 400 MG/KG/DAY; 0, 100, 200, 400 MG/KG/DAY.